Should I stay or should I go: β-catenin decides under stress

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1796, Issue 2, 2009, Pages 63-74

  Hoogeboom, Diana ^a   Burgering, Boudewijn M T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Beta catenin; Cancer; Forkhead; Oxidative stress; Signalling pathway; Transcription

Indexed keywords

BETA CATENIN; CELL PROTEIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN C JUN; PROTEIN DAF 2; RAL PROTEIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; WNT PROTEIN;

AGING; CANCER GROWTH; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; GENE EXPRESSION; HUMAN; LONGEVITY; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION REGULATION;

AGING; ANIMALS; BETA CATENIN; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; WNT PROTEINS;

CAENORHABDITIS ELEGANS;

EID: 70349172032     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.02.002     Document Type: Review

References (109)

1. Paravicini T.M., and Touyz R.M. Redox signaling in hypertension. Cardiovasc. Res. 71 (2006) 247-258
2. Chiarugi P. From anchorage dependent proliferation to survival: lessons from redox signalling. IUBMB life 60 (2008) 301-307
3. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84
4. Honda Y., and Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 13 (1999) 1385-1393
5. Essers M.A., Weijzen S., de Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., and Burgering B.M. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23 (2004) 4802-4812
6. Essers M.A., de Vries-Smits L.M., Barker N., Polderman P.E., Burgering B.M., and Korswagen H.C. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science (New York, NY) 308 (2005) 1181-1184
7. Almeida M., Han L., Martin-Millan M., O'Brien C.A., and Manolagas S.C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282 (2007) 27298-27305
8. Hoogeboom D., Essers M.A., Polderman P.E., Voets E., Smits L.M., and Burgering B.M. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J. Biol. Chem. 283 (2008) 9224-9230
9. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., and Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 217-221
10. Radeke H.H., Meier B., Topley N., Floge J., Habermehl G.G., and Resch K. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int. 37 (1990) 767-775
11. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
12. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273 (1998) 15366-15372
13. Giannoni E., Buricchi F., Raugei G., Ramponi G., and Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol. 25 (2005) 6391-6403
14. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
15. Lee S.S., Kennedy S., Tolonen A.C., and Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science (New York, N.Y) 300 (2003) 644-647
16. Oh S.W., Mukhopadhyay A., Svrzikapa N., Jiang F., Davis R.J., and Tissenbaum H.A. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4494-4499
17. Wang M.C., Bohmann D., and Jasper H. JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. Dev. Cell. 5 (2003) 811-816
18. Wang M.C., Bohmann D., and Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121 (2005) 115-125
19. Gotoh Y., and Cooper J.A. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J. Biol. Chem. 273 (1998) 17477-17482
20. Nadeau P.J., Charette S.J., Toledano M.B., and Landry J. Disulfide bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol. Biol. Cell 18 (2007) 3903-3913
21. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
22. Matsuura H., Nishitoh H., Takeda K., Matsuzawa A., Amagasa T., Ito M., Yoshioka K., and Ichijo H. Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK signaling pathway. A new mode of regulation of the MAP kinase cascade. J. Biol. Chem. 277 (2002) 40703-40709
23. Xu W., and Kimelman D. Mechanistic insights from structural studies of beta-catenin and its binding partners. J. Cell Sci. 120 (2007) 3337-3344
24. Giles R.H., Lolkema M.P., Snijckers C.M., Belderbos M., van der Groep P., Mans D.A., van Beest M., van Noort M., Goldschmeding R., van Diest P.J., Clevers H., and Voest E.E. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene 25 (2006) 3065-3070
25. Toualbi K., Guller M.C., Mauriz J.L., Labalette C., Buendia M.A., Mauviel A., and Bernuau D. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes. Oncogene 26 (2007) 3492-3502
26. Moon R.T., Bowerman B., Boutros M., and Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science (New York, N.Y 296 (2002) 1644-1646
27. Yamaguchi T.P., Bradley A., McMahon A.P., and Jones S. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development (Cambridge, England) 126 (1999) 1211-1223
28. Li H., and Zhan M. Systematic intervention of transcription for identifying network response to disease and cellular phenotypes. Bioinformatics (Oxford, England) 22 (2006) 96-102
29. Cadigan K.M., and Liu Y.I. Wnt signaling: complexity at the surface. J. Cell Sci. 119 (2006) 395-402
30. Barker N., Morin P.J., and Clevers H. The yin-yang of TCF/beta-catenin signaling. Adv. Cancer Res. 77 (2000) 1-24
31. Harwood A.J. Signal transduction in development: holding the key. Dev. Cell 2 (2002) 384-385
32. Kimelman D., and Xu W. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25 (2006) 7482-7491
33. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., and Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24 (2005) 1571-1583
34. Levanon D., Goldstein R.E., Bernstein Y., Tang H., Goldenberg D., Stifani S., Paroush Z., and Groner Y. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11590-11595
35. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., and Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
36. Bienz M., and Clevers H. Linking colorectal cancer to Wnt signaling. Cell 103 (2000) 311-320
37. Kinzler K.W., and Vogelstein B. Breast cancer. What's mice got to do with it?. Nature 382 (1996) 672
38. Morin P.J. Beta-catenin signaling and cancer. Bioessays 21 (1999) 1021-1030
39. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science (New York, N.Y) 303 (2004) 1483-1487
40. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
41. Reya T., O'Riordan M., Okamura R., Devaney E., Willert K., Nusse R., and Grosschedl R. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13 (2000) 15-24
42. Funato Y., Michiue T., Asashima M., and Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat. Cell Biol. 8 (2006) 501-508
43. Shin S.Y., Chin B.R., Lee Y.H., and Kim J.H. Involvement of glycogen synthase kinase-3beta in hydrogen peroxide-induced suppression of Tcf/Lef-dependent transcriptional activity. Cell. Signal. 18 (2006) 601-607
44. Shaw M., Cohen P., and Alessi D.R. The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J. 336 Pt. 1 (1998) 241-246
45. Li L., Yuan H., Xie W., Mao J., Caruso A.M., McMahon A., Sussman D.J., and Wu D. Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J. Biol. Chem. 274 (1999) 129-134
46. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14 (2005) 1583-1588
47. Noselli S., and Agnes F. Roles of the JNK signaling pathway in Drosophila morphogenesis. Curr. Opin. Genet. Dev. 9 (1999) 466-472
48. Ishitani T., Ninomiya-Tsuji J., Nagai S., Nishita M., Meneghini M., Barker N., Waterman M., Bowerman B., Clevers H., Shibuya H., and Matsumoto K. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399 (1999) 798-802
49. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
50. Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., and Greenberg M.E. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21 (2001) 952-965
51. Kops G.J., de Ruiter N.D., De Vries-Smits A.M., Powell D.R., Bos J.L., and Burgering B.M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398 (1999) 630-634
52. Jacobs F.M., van der Heide L.P., Wijchers P.J., Burbach J.P., Hoekman M.F., and Smidt M.P. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 278 (2003) 35959-35967
53. van der Heide L.P., Jacobs F.M., Burbach J.P., Hoekman M.F., and Smidt M.P. FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling. Biochem. J. 391 (2005) 623-629
54. Jagani Z., Singh A., and Khosravi-Far R. FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis. Biochim. Biophys. Acta 1785 (2008) 63-84
55. Myatt S.S., and Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. 7 (2007) 847-859
56. van der Horst A., and Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8 (2007) 440-450
57. Paik J.H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., Miao L., Tothova Z., Horner J.W., Carrasco D.R., Jiang S., Gilliland D.G., Chin L., Wong W.H., Castrillon D.H., and DePinho R.A. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128 (2007) 309-323
58. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., Huang T.T., Bos J.L., Medema R.H., and Burgering B.M. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419 (2002) 316-321
59. Burgering B.M., and Medema R.H. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol. 73 (2003) 689-701
60. Daitoku H., and Fukamizu A. FOXO transcription factors in the regulatory networks of longevity. J. Biochem. 141 (2007) 769-774
61. Hasselgren P.O. Ubiquitination, phosphorylation, and acetylation-triple threat in muscle wasting. J. Cell. Physiol. 213 (2007) 679-689
62. Sedding D.G. FoxO transcription factors in oxidative stress response and ageing-a new fork on the way to longevity?. Biol. Chem. 389 (2008) 279-283
63. Cunningham M.A., Zhu Q., and Hammond J.M. FoxO1a can alter cell cycle progression by regulating the nuclear localization of p27kip in granulosa cells. Mol. Endocrinol. (Baltim., Md) 18 (2004) 1756-1767
64. Kenyon C., Chang J., Gensch E., Rudner A., and Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 366 (1993) 461-464
65. Robinson J.A., Chatterjee-Kishore M., Yaworsky P.J., Cullen D.M., Zhao W., Li C., Kharode Y., Sauter L., Babij P., Brown E.L., Hill A.A., Akhter M.P., Johnson M.L., Recker R.R., Komm B.S., and Bex F.J. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 281 (2006) 31720-31728
66. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., and Luo S.Q. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem. Biophys. Res. Commun. 314 (2004) 197-207
67. de Boer J., Andressoo J.O., de Wit J., Huijmans J., Beems R.B., van Steeg H., Weeda G., van der Horst G.T., van Leeuwen W., Themmen A.P., Meradji M., and Hoeijmakers J.H. Premature aging in mice deficient in DNA repair and transcription. Science (New York, N.Y 296 (2002) 1276-1279
68. Jilka R.L. Osteoblast progenitor fate and age-related bone loss. J. Musculoskelet. Neuronal Interact. 2 (2002) 581-583
69. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Hee Park S., Thompson T., Karsenty G., Bradley A., and Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature 415 (2002) 45-53
70. Holmquist-Mengelbier L., Fredlund E., Lofstedt T., Noguera R., Navarro S., Nilsson H., Pietras A., Vallon-Christersson J., Borg A., Gradin K., Poellinger L., and Pahlman S. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer cell 10 (2006) 413-423
71. Semenza G.L., Agani F., Booth G., Forsythe J., Iyer N., Jiang B.H., Leung S., Roe R., Wiener C., and Yu A. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int. 51 (1997) 553-555
72. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
73. Metzen E., Berchner-Pfannschmidt U., Stengel P., Marxsen J.H., Stolze I., Klinger M., Huang W.Q., Wotzlaw C., Hellwig-Burgel T., Jelkmann W., Acker H., and Fandrey J. Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J. Cell Sci. 116 (2003) 1319-1326
74. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., and Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
75. Greijer A.E., and van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57 (2004) 1009-1014
76. Schiller C.M. Flow of reducing equivalents into isolated intestinal mitochondria. Metab. Clin. Exp. 28 (1979) 105-112
77. Chandel N.S., McClintock D.S., Feliciano C.E., Wood T.M., Melendez J.A., Rodriguez A.M., and Schumacker P.T. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275 (2000) 25130-25138
78. Guzy R.D., and Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 91 (2006) 807-819
79. Metzen E., Zhou J., Jelkmann W., Fandrey J., and Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14 (2003) 3470-3481
80. Kaidi A., Williams A.C., and Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9 (2007) 210-217
81. Emerling B.M., Weinberg F., Liu J.L., Mak T.W., and Chandel N.S. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2622-2627
82. Bakker W.J., Harris I.S., and Mak T.W. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol. Cell 28 (2007) 941-953
83. Scott B.A., Avidan M.S., and Crowder C.M. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science (New York, N.Y 296 (2002) 2388-2391
84. Ginouves A., Ilc K., Macias N., Pouyssegur J., and Berra E. PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 4745-4750
85. Liu Y., Cox S.R., Morita T., and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77 (1995) 638-643
86. Zhang W., Patil S., Chauhan B., Guo S., Powell D.R., Le J., Klotsas A., Matika R., Xiao X., Franks R., Heidenreich K.A., Sajan M.P., Farese R.V., Stolz D.B., Tso P., Koo S.H., Montminy M., and Unterman T.G. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281 (2006) 10105-10117
87. Mammucari C., Schiaffino S., and Sandri M. Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy 4 (2008) 524-526
88. Hibi M., Lin A., Smeal T., Minden A., and Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7 (1993) 2135-2148
89. Minet E., Michel G., Mottet D., Piret J.P., Barbieux A., Raes M., and Michiels C. c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells. Exp. Cell Res. 265 (2001) 114-124
90. Bohmann D., Bos T.J., Admon A., Nishimura T., Vogt P.K., and Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science (New York, N.Y 238 (1987) 1386-1392
91. Cohen D.R., Ferreira P.C., Gentz R., Franza Jr. B.R., and Curran T. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev. 3 (1989) 173-184
92. Hai T., and Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3720-3724
93. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. 3 (2003) 859-868
94. Nikitovic D., Holmgren A., and Spyrou G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 242 (1998) 109-112
95. Hildesheim J., Salvador J.M., Hollander M.C., and Fornace Jr. A.J. Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK. J. Biol. Chem. 280 (2005) 17221-17226
96. Fritz G., Grosch S., Tomicic M., and Kaina B. APE/Ref-1 and the mammalian response to genotoxic stress. Toxicology 193 (2003) 67-78
97. Nateri A.S., Spencer-Dene B., and Behrens A. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437 (2005) 281-285
98. Gan X.Q., Wang J.Y., Xi Y., Wu Z.L., Li Y.P., and Li L. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J. Cell Biol. 180 (2008) 1087-1100
99. Gilley J., and Ham J. Evidence for increased complexity in the regulation of Bim expression in sympathetic neurons: involvement of novel transcriptional and translational mechanisms. DNA Cell Biol. 24 (2005) 563-573
100. Murphy D.J., Junttila M.R., Pouyet L., Karnezis A., Shchors K., Bui D.A., Brown-Swigart L., Johnson L., and Evan G.I. Distinct thresholds govern Myc's biological output in vivo. Cancer cell 14 (2008) 447-457
101. Campisi J. From cells to organisms: can we learn about aging from cells in culture?. Exp. Gerontol. 36 (2001) 607-618
102. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., and Rando T.A. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (New York, N.Y 317 (2007) 807-810
103. Liu H., Fergusson M.M., Castilho R.M., Liu J., Cao L., Chen J., Malide D., I.I. Rovira, Schimel D., Kuo C.J., Gutkind J.S., Hwang P.M., and Finkel T. Augmented Wnt signaling in a mammalian model of accelerated aging. Science (New York, N.Y.) 317 (2007) 803-806
104. Wolf I., Levanon-Cohen S., Bose S., Ligumsky H., Sredni B., Kanety H., Kuro-o M., Karlan B., Kaufman B., Koeffler H.P., and Rubinek T. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27 (2008) 7094-7105
105. Yamamoto M., Clark J.D., Pastor J.V., Gurnani P., Nandi A., Kurosu H., Miyoshi M., Ogawa Y., Castrillon D.H., Rosenblatt K.P., and Kuro-o M. Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280 (2005) 38029-38034
106. Rattan S.I. Hormetic mechanisms of anti-aging and rejuvenating effects of repeated mild heat stress on human fibroblasts in vitro. Rejuvenation Res. 7 (2004) 40-48
107. Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A., and Oren M. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20 (2001) 4912-4922
108. Ramsey M.R., and Sharpless N.E. ROS as a tumour suppressor?. Nat. Cell Biol. 8 (2006) 1213-1215
109. Takahashi A., Ohtani N., Yamakoshi K., Iida S., Tahara H., Nakayama K., Nakayama K.I., Ide T., Saya H., and Hara E. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8 (2006) 1291-1297